In addition to being one of August’s Most Attractive Stocks, Medtronic was highlighted by my colleague Tom Brakke at Research Puzzle Pix.
Like all of our Most Attractive Stocks the company has (1) high and rising economic profits (as distinct from accounting profits**) and (2) a cheap valuation. As shown in our report on MDT, the company’s ROIC is in the Top Quintile of all the companies we cover and its economic earnings are growing. At the same time, the stock’s valuation implies that MDT’s profits will decline by 50% and never grow again. In other words, the stock market is predicting a permanent decline of 50% in MDT’s profits. I’d say those are some low expectations.
HIDDEN GEM: Our discounted cash flow analysis shows that MDT’s current valuation (stock price of $31.95) implies that the company’s profits will decline by 50% and never grow again. Our economic earnings models shows profits are growing, not declining, which makes the Risk/Reward for MDT Very Attractive.
For details on what causes the difference between Economic Versus Accounting Profits, see Appendix 3 on page 10 of our report on MDT. See Appendix 4 to learn how MDT increased NOPAT by cutting costs and increased its NOPAT Margin from 24.5% to 25.6%. See Appendix 5 for details on how MDT grew Invested Capital slower than revenue and drove Invested Capital Turns higher. Appendix 7 (in the Return on Invested Capital section) shows how the improved NOPAT Margin and rising Invested Capital Turns result in an increase in ROIC (to 14.5% from 13.4%) and Economic Profit, which rose by $345mm.
As per Investment Strategy 101 and How to make money picking stocks, MDT fits the profile of a great stock to buy.
**See Finance 101 and Economic Versus Accounting Profits for more detail on why accounting profits are not reliable indicators of corporate profitability or value creation.
1 Response to "Stock Pick of the Week: Buy Medtronic Inc. (MDT) – Very Attractive Rating"
[…] News Medtronic Announces Settlement of Heart Lead Litigation Twin Cities Marathon twin cities marathon Angiotech Announces That Cook Medical’s Zilver® Ptx® Drug-Eluting Stent … Tonometry Through Eyelid Allows to Obtain Intraocular Pressure Independent … Medtronic Receives European CE Mark Approval for Deep Brain … Medtronic lancia in Europa L’innovativo sistema di DEPOSIZIONE dI … Bacterin International (BIHI): A Takeout Target in 2011 Trading notes Medtronic Inc (NYSE:MDT) publishes 2010 Corporate Citizenship Report FDA approves stent stunt Stock Pick of the Week: Buy Medtronic Inc. (MDT) — Very Attractive Rating […]